Takeshi Kawakami

11PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 05, 2026
Impact of prior nivolumab on treatment outcomes of taxane plus ramucirumab in advanced gastric cancer.

|Feb 05, 2026
Safety and Efficacy of Concomitant Administration of Nanoliposomal Irinotecan + 5-Fluorouracil/Levo-Leucovorin for Pancreatic Cancer.

Akane Wakabayashi, Rei Tanaka, Yurie Fukumuro

|Feb 02, 2026
ANGPTL3 in the Peripheral Circulation Is Associated with Resistance to Anti-PD1 Therapy in Advanced Gastric Cancer.

Chie Kudo-Saito, Hirokazu Shoji, Kengo Nagashima

|Oct 29, 2025
Correction: Miyajima, Y.; Kawakami, T. Treatment Selection for Patients with HER2-Negative Metastatic Gastric Cancer Expressing Claudin 18.2 and PD-L1. Cancers 2025, 17, 1120.

Yusuke Miyajima, Takeshi Kawakami

|May 23, 2025
Randomized Phase III Trial of Ramucirumab Beyond Progression Plus Irinotecan in Patients With Ramucirumab-Refractory Advanced Gastric Cancer: RINDBeRG Trial.

Daisuke Sakai, Shigenori Kadowaki, Ryohei Kawabata

|Apr 14, 2025
Treatment Selection for Patients with HER2-Negative Metastatic Gastric Cancer Expressing Claudin 18.2 and PD-L1.

Yusuke Miyajima, Takeshi Kawakami

Pageof 2

Frequent Collaborators

3 joint publications

Kei Muro

3 joint publications

Yusuke Miyajima

2 joint publications

Hisato Kawakami

2 joint publications

Narikazu Boku